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EXECUTIVE SUMMARY: SEVENTH REPORT
TO THE CONGRESS ON THE OPERATION
OF THE ANDEAN TRADE PREFERENCE
ACT As AMENDED*THE Andean Trade Preference Act (ATPA), as amended by the
Andean Trade Promotion and Drug Eradication Act (ATPDEA)
(jointly referred to as the ATPA/ATPDEA), requires the U.S.
Trade Representative (USTR) to submit a report to Congress on the op-
eration of the program no later than June 30th every year during the pe-
riod that the program is in effect. Congress directed that these reports
include a review of the ATPA/ATPDEA beneficiary countries based on
the eligibility criteria and considerations described in the statute. This is
the seventh USTR report to Congress on the ATPA/ATPDEA, and cov-
ers the year 2012, unless otherwise indicated.
The ATPDEA renewed and expanded the ATPA, which had expired
on December 4, 2001, providing beneficiary countries duty-free access to
the U.S. market for any product not specifically excluded. Sections
203(c) and 203(d) and Section 204 (b)(6)(B) of ATPA, as amended by the
ATPDEA, require that countries meet certain criteria in order to be des-
ignated as an ATPDEA beneficiary country and to maintain such benefi-
ciary status. In Presidential Proclamation 7616 of October 31, 2002, the
President designated all four ATPA beneficiary countries-Bolivia, Co-
lombia, Ecuador, and Peru-as ATPDEA beneficiary countries. The
ATPA, as amended, was originally set to expire on December 31, 2006,
but Congress has enacted several extensions. On February 12, 2011, the
privileges under the ATPA/ATPDEA lapsed but were reauthorized, ret-
roactively, on October 21, 2011 for eligible countries pursuant to section
501 of the United States-Colombia Trade Promotion Agreement Imple-
mentation Act (the Implementation Act) (P.L. 112-42).
In its previous extension of the program, Congress stipulated that Bo-
livia would not receive ATPA/ATPDEA benefits after June 30, 2009, un-
less by that date the President determined that Bolivia was satisfying the
program's eligibility criteria. In a June 30, 2009 report to Congress, the
President did not determine that Bolivia satisfied the program's eligibility
requirements. As a result, no ATPA/ATPDEA benefits remained in ef-
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fect for Bolivia after that date.'
Further, Section 201 of the Omnibus Trade Act of 2010 (P.L. 111-344),
which re-authorized the ATPA/ATPDEA, terminated any preferential
treatment available under ATPA/ATPDEA to Peru, after December 31,
2010. Peru has a free trade agreement with the United States.
At the time of the 2011 re-authorization, only Colombia and Ecuador
were eligible beneficiary countries. Colombia is no longer an eligible
beneficiary country under the ATPA as of May 15, 2012, when the United
States-Colombia Trade Promotion Agreement (CTPA) entered into force
(19 U.S.C. 3805 Note). Unless renewed by Congress, the ATPA/
ATPDEA will expire on July 31, 2013.
The objectives of the ATPA/ATPDEA are to promote broad-based ec-
onomic development, and diversification of exports, and to help defeat
the scourge of drug trafficking by providing sustainable economic alterna-
tives to drug-crop production in beneficiary countries. This report 2 ex-
amines Ecuador's progress toward achieving these goals and its
performance with respect to the program's eligibility criteria.
Total U.S. imports from ATPA/ATPDEA countries (i.e., Colombia and
Ecuador), whether or not under the program, rose from $31.9 billion in
2011 to $34.0 billion in 2012, or 6.5 percent. Measured U.S. imports spe-
cifically under the ATPA/ATPDEA program rose from $4.4 billion in
2011 to $11.4 billion in 2012. However, the 2011 figure does not re-
present normal operation of the program due to the 2011 nine-month
lapse in the program and issues associated with retroactive applications
for preferences.
In furtherance of the ATPA/ATPDEA's objectives, in May 2004, the
United States initiated free trade agreement (FTA) negotiations with
Peru, Colombia, and Ecuador, with Bolivia participating as an observer.
On December 7, 2005, the United States and Peru concluded negotiations
on the United States-Peru Trade Promotion Agreement (PTPA) and
signed the agreement on April 12, 2006. The PTPA entered into force on
February 1, 2009. The United States and Colombia concluded negotia-
tions on the CTPA on February 27, 2006, and signed the agreement on
November 22, 2006. The Implementation Act was enacted on October
21, 2011, and included the re-authorization of the ATPA/ATPDEA. Ne-
gotiations on an FTA with Ecuador took place through March 2006, but
did not conclude. The United States did not initiate negotiations on an
FTA with Bolivia.
This report is organized as follows. Chapter 1 briefly describes the key
sections of the ATPA/ATPDEA, including the requirements and the des-
ignation of ATPA/ATPDEA beneficiary countries. Chapter 2 highlights
trade between the United States and the ATPA/ATPDEA beneficiary
countries. Chapter 3 evaluates Ecuador's compliance with the eligibility
1. President Bush suspended Bolivia's designation as a beneficiary country under the
ATPA/ATPDEA, effective December 15, 2008, citing Bolivia's failure to meet the
program's eligibility criteria related to counternarcotics cooperation.
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criteria of the statute and discusses the ATPA/ATPDEA's effect on trade
with Ecuador. Chapter 4 summarizes responses by interested parties to
the Administration's notice in the Federal Register inviting comments on
the program, as mandated by Section 203(f) of the ATPA/ATPDEA. Fi-
nally, Chapter 5 describes the operation of the ATPA/ATPDEA benefici-
ary review process.
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